SCHEMBL24974233

SCHEMBL24974233

CC1(C)c2ccccc2N(c2ccc3c(c2)P(=O)(c2ccccc2)c2ccccc2N3c2ccccc2)c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 7/20 0.35
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
GAA P10253 2/20 0.33
KMT2A Q03164 2/20 0.33
ITGB2 P05107 1/20 0.32
ICAM1 P05362 1/20 0.32
ITGAL P20701 1/20 0.32
USP2 O75604 2/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
THPO P40225 1/20 0.32
MAPK1 P28482 1/20 0.30
NPSR1 Q6W5P4 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24974117 0.92 PGR (0.33) PGRALDH1A1MAPTMEN1GAA
SCHEMBL24974119 0.89 PGR (0.33) PGRALDH1A1MAPTITGB2ICAM1
SCHEMBL24974118 0.89 PGR (0.35) PGRALDH1A1MAPTMEN1GAA
SCHEMBL24974225 0.89 ITGB2 (0.33) PGRALDH1A1MAPTMEN1GAA
SCHEMBL22063753 0.88 ITGB2 (0.34) PGRALDH1A1MAPTMEN1GAA
SCHEMBL24974123 0.88 PGR (0.33) PGRMAPTITGB2ICAM1ITGAL
SCHEMBL19318169 0.85 ITGB2 (0.31) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL24974679 0.83 HDAC6 (0.31) ITGB2ICAM1ITGAL
SCHEMBL24974079 0.83 MEN1 (0.32) MAPTMEN1KMT2AITGB2ICAM1
SCHEMBL19318118 0.83 ITGB2 (0.31) ALDH1A1MAPTMEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572378-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572378-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 PGR 1471/4885ALDH1A1 4/4885MAPT 1799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.